Winqvist R - Search Results

1

Mendelian randomisation study of smoking exposure in relation to breast cancer risk.

Park HA, Neumeyer S, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE, Brauch H, Brenner H, Brucker SY, Burwinkel B, Campa D, Canzian F, Castelao JE, Chanock SJ, Chenevix-Trench G, Clarke CL; NBCS Collaborators; Conroy DM, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dos-Santos-Silva I, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fritschi L, García-Closas M, García-Sáenz JA, Gaudet MM, Giles GG, Glendon G, Goldberg MS, Goldgar DE, González-Neira A, Grip M, Guénel P, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Han S, Harkness EF, Hart SN, He W, Heemskerk-Gerritsen BAM, Hopper JL, Hunter DJ; ABCTB Investigators; kConFab Investigators; Jager A, Jakubowska A, John EM, Jung A, Kaaks R, Kapoor PM, Keeman R, Khusnutdinova E, Kitahara CM, Koppert LB, Koutros S, Kristensen VN, Kurian AW, Lacey J, Lambrechts D, Le Marchand L, Lo WY, Lubiński J, Mannermaa A, Manoochehri M, Margolin S, Martinez ME, Mavroudis D, Meindl A, Menon U, … See abstract for full author list ➔ Park HA, et al. Among authors: winqvist r. Br J Cancer. 2021 Oct;125(8):1135-1145. doi: 10.1038/s41416-021-01432-8. Epub 2021 Aug 2. Br J Cancer. 2021. PMID: 34341517 Free PMC article.

2

Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.

Winqvist R, Hampton GM, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I, et al. Winqvist R, et al. Cancer Res. 1995 Jun 15;55(12):2660-4. Cancer Res. 1995. PMID: 7780982

3

A point mutation in the putative TATA box, detected in nondiseased individuals and patients with hereditary breast cancer, decreases promoter activity of the 17 beta-hydroxysteroid dehydrogenase type 1 gene 2 (EDH17B2) in vitro.

Peltoketo H, Piao Y, Mannermaa A, Ponder BA, Isomaa V, Poutanen M, Winqvist R, Vihko R. Peltoketo H, et al. Among authors: winqvist r. Genomics. 1994 Sep 1;23(1):250-2. doi: 10.1006/geno.1994.1487. Genomics. 1994. PMID: 7829082

4

Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.

Soini Y, Mannermaa A, Winqvist R, Kamel D, Poikonen K, Kiviniemi H, Pääkkö P. Soini Y, et al. Among authors: winqvist r. J Histochem Cytochem. 1994 Jun;42(6):795-803. doi: 10.1177/42.6.7910618. J Histochem Cytochem. 1994. PMID: 7910618

5

Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.

Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA. Hampton GM, et al. Among authors: winqvist r. Cancer Res. 1994 Sep 1;54(17):4586-9. Cancer Res. 1994. PMID: 8062246

6

Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay.

Mannermaa A, Peltoketo H, Winqvist R, Ponder BA, Kiviniemi H, Easton DF, Poutanen M, Isomaa V, Vihko R. Mannermaa A, et al. Among authors: winqvist r. Hum Genet. 1994 Mar;93(3):319-24. doi: 10.1007/BF00212030. Hum Genet. 1994. PMID: 8125484

7

Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.

Winqvist R, Mannermaa A, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee W. Winqvist R, et al. Cancer Res. 1993 Oct 1;53(19):4486-8. Cancer Res. 1993. PMID: 8402619

8

European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.

Launonen V, Laake K, Huusko P, Niederacher D, Beckmann MW, Barkardottir RB, Geirsdottir EK, Gudmundsson J, Rio P, Bignon YJ, Seitz S, Scherneck S, Bièche I, Champème MH, Birnbaum D, White G, Varley J, Sztán M, Olah E, Osorio A, Benitez J, Spurr N, Velikonja N, Peterlin B, Winqvist R, et al. Launonen V, et al. Among authors: winqvist r. Br J Cancer. 1999 May;80(5-6):879-82. doi: 10.1038/sj.bjc.6690435. Br J Cancer. 1999. PMID: 10360669 Free PMC article.

9

Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites.

Rapakko K, Allinen M, Syrjäkoski K, Vahteristo P, Huusko P, Vähäkangas K, Eerola H, Kainu T, Kallioniemi OP, Nevanlinna H, Winqvist R. Rapakko K, et al. Among authors: winqvist r. Br J Cancer. 2001 Jan 5;84(1):116-9. doi: 10.1054/bjoc.2000.1530. Br J Cancer. 2001. PMID: 11139324 Free PMC article.

10

Mutation analysis of the CHK2 gene in families with hereditary breast cancer.

Allinen M, Huusko P, Mäntyniemi S, Launonen V, Winqvist R. Allinen M, et al. Among authors: winqvist r. Br J Cancer. 2001 Jul 20;85(2):209-12. doi: 10.1054/bjoc.2001.1858. Br J Cancer. 2001. PMID: 11461078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page